Furthermore, a 2021 study by Zhang and colleagues describe a U-shaped curve with regard to the relationship between Hb and mortality and poor functional outcome, suggesting that both anemia and polycythemia alike are detrimental in morbidity and mortality following AIS. The gene discussed is GSTM1; the disease is polycythemia.